Journal of Histochemistry and Cytochemistry Priciples for Free Access to Science
  Search:   
    >> Advanced Search

Guidelines | Subscriptions | About | exPRESS - Current - Archive | Business Information | Contact
Originally published as JHC exPRESS on April 3, 2006.
doi:10.1369/jhc.5A6869.2006
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jhc.5A6869.2006v1
54/8/897    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lin, W.-W.
Right arrow Articles by Yang, V. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lin, W.-W.
Right arrow Articles by Yang, V. C.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Journal of Histochemistry and Cytochemistry
Volume 54 (8): 897-904, 2006
Copyright ©The Histochemical Society, Inc.

Caveolin-1 Expression Is Associated with Plaque Formation in Hypercholesterolemic Rabbits

Wei-Wen Lin, Yu-Chun Lin, Ti-Yu Chang, Shu-Huai Tsai, Hon-Chun Ho, Ying-Tsung Chen and Vivian C. Yang

Department of Life Science, Tunghai University, Taichung, Taiwan, Republic of China (W-WL,Y-CL,S-HT,H-CH,VCY), and Division of Cardiology, Taichung Veterans General Hospital, Taichung, Taiwan, Republic of China (W-WL,T-YC,H-CH,Y-TC)

Correspondence to: Vivian C. Yang, Department of Life Science, Tunghai University, 181, Section 3, Taichung Harbor Road, Taichung, Taiwan, R.O.C. E-mail: vcyang{at}thu.edu.tw


   Summary
Top
 Summary
Introduction
 Materials and Methods
 Results
 Discussion
 Literature Cited
 
Caveolin-1, the major structural protein of caveolae, is present in several cell types known to play a role in the development of atherosclerosis. In this study, the distribution and expression of caveolin-1 in the arterial walls were studied in hypercholesterolemic rabbits. Immunohistochemical results indicated that the staining intensity of caveolin-1 reached a high level in the arterial intima at 5 weeks after high-cholesterol-diet treatment and decreased to a very low level at 8 weeks when atheromatous plaques appeared. Western blot analysis showed that in rabbits fed a high-cholesterol diet for 5 weeks, the expression of caveolin-1 reached its highest level and then decreased from 8 to 12 weeks. The proliferative activity of smooth muscle cells (SMCs) decreased to the lowest level at 5 weeks and then increased at 8 and 12 weeks. Nitric oxide synthase activity gradually decreased in animals fed a high-cholesterol diet throughout the experiment. These studies demonstrate that the change in abundance of caveolin-1 is associated with SMC proliferation in the formation of atheromatous plaque after hypercholesterolemia insult. (J Histochem Cytochem 54:897–904, 2006)

Key Words: caveolin-1 • hypercholesterolemia • atheroma • smooth muscle cell proliferation • nitric oxide synthase activity


   Introduction
Top
 Summary
 Introduction
Materials and Methods
 Results
 Discussion
 Literature Cited
 
CAVEOLIN PROTEINS are expressed in most cell types known to play an important role in the development of atherosclerosis. Among the caveolin family, caveolin-1, the major structural protein of caveolae, is mainly expressed in endothelial cells, macrophages, and smooth muscle cells (SMCs) (Chang et al. 1994Go; Scherer et al. 1997Go; Matveev et al. 1999Go; Frank and Lisanti 2004Go). Apart from having a structural function within caveolae, these proteins have the capacity to bind cholesterol as well as a variety of proteins such as receptors, Src-like kinases, G-proteins, H-Ras, and nitric oxide synthases (NOS) (Smart et al. 1999Go; Feron and Kelly 2001Go). Early studies have suggested that caveolin-1 is involved in the regulation of cellular cholesterol homeostasis and promotes cellular cholesterol efflux (Fielding and Fielding 1997Go; Frank et al. 2001Go; Fu et al. 2004Go). If cell free cholesterol increases via increased extracellular levels of low-density lipoprotein (LDL), preformed caveolin moves from intracellular pools to the cell surface. In the meantime, caveolin synthesis is upregulated transcriptionally, and caveolae, caveolin-1, and free cholesterol efflux levels increase (Fielding and Fielding 1997Go). On the contrary, it has been shown that oxysterols reduce the increase in caveolin mRNA levels and free cholesterol efflux in fibroblast (Fielding et al. 1997Go). Because caveolin-1 is highly expressed in endothelial cells, caveolae must play an important role in the regulation of the lipid exchange between the blood and peripheral tissues. In SMCs, caveolin-1 can negatively regulate cell proliferation (Peterson et al. 2003Go). In caveolin-1 (–/–)-deficient mice, there is a dramatic enhancement of neointima hyperplasia (Hassan et al. 2004Go). Therefore, a change in caveolin-1 and caveolae abundance could directly impact vascular function and result in the development of atheroma.

Another important function of caveolin-1 is its ability to negatively regulate endothelial NOS (eNOS) activity (Feron et al. 2001Go). eNOS becomes hyperactivated in the absence of caveolin-1 (Bucci et al. 2000Go). Series experiments have demonstrated that Cav-1/caveolae regulate three major vascular functions dependent on NO and Ca2+ signaling: endothelium-dependent relaxation of arteries, myogenic tone, and stimulated contractility (Drab et al. 2001Go). Many studies have suggested that eNOS plays a major role in the development of atherosclerosis (Drexler 1999Go; Feron et al. 1999Go). It was reported that vascular cell adhesion molecule 1 (VCAM-1) was downregulated by e-NOS and NO (Takahashi et al. 1996Go; Huo and Ley 2001Go; Kawashima et al. 2001Go). NO was also shown to prevent SMC proliferation and migration in culture (Garg and Hassid 1989Go). Therefore, regulation of eNOS by caveolin-1 in endothelial cells may indirectly cause SMCs to develop into atherosclerosis. Recently, in vivo studies demonstrated that decreased expression of caveolin-1 was observed in dogs with hypertrophic cardiomyopathy (Piech et al. 2002Go). Dissociation of caveolin from caveolae is also associated with aging and myocardial infarction (Ratajczak et al. 2003Go). In this study, we established an experimental hypercholesterolemic rabbit model to analyze the distribution and expression of caveolin-1 in the arterial walls. In addition, we investigated whether alterations in caveolin-1 distribution and expression were related to SMC proliferation and eNOS dysfunction during hypercholesterolemia.


   Materials and Methods
Top
 Summary
 Introduction
 Materials and Methods
Results
 Discussion
 Literature Cited
 
Animals and Diet
Forty New Zealand White rabbits weighing ~4 kg were fed a 2% cholesterol diet for 12 weeks. A control group consisted of 40 rabbits fed a standard diet (Fu-Shou Co.; Taichung, Taiwan). Rabbits were weighed and total cholesterol, HDL-cholesterol, and LDL-cholesterol contents were determined weekly.

Analysis of Plasma Cholesterol Levels
Blood (1.5 ml) from rabbit ears was collected into Eppendorf vials and spun at 5000 x g for 10 min. Total plasma cholesterol and LDL cholesterol were measured spectrophotometrically using LDL-Cholesterin and Cholesterin Kits (Merck KgaA; Darmstadt, Germany).

Immunohistochemistry
Animals were anesthetized with a mixture of ketamine (40 mg/kg) and xylazine (5 mg/kg) given IM. After sacrificing, the carotid artery, aortic arch, thoracic aorta, and coronary artery were dissected and washed with PBS, dehydrated in graded alcohol, and embedded in paraffin. Tissues were cut into 5-µm sections, deparaffinized with xylene, and then rehydrated in a graded series of ethanol for hematoxylin and eosin staining and immunohistochemistry. Caveolin-1 and {alpha}-actin were detected by the streptavidin–biotin amplification method reported previously (Elias et al. 1989Go). In brief, tissue sections were washed in a running water bath for 10 min and then heated in 10 mM citric acid buffer (pH 6.0) for 15 min in a microwave oven (800 W) to enhance antigen retrieval. Endogenous peroxidase activity was quenched by treating the tissue sections with 3% hydrogen peroxide for 10 min. Nonspecific background was eliminated by incubating the tissue sections with non-immune serum. After washing with PBS, tissue sections were incubated with rabbit anti-human caveolin-1 antibody [1:200 (v/v); Santa Cruz Biotechnology, Santa Cruz, CA] and mouse anti-human {alpha}-actin antibody [1:200 (v/v); Lab Vision Corp., Fremont, CA] at 37C for 1 hr, followed by the addition of either biotinylated goat anti-rabbit IgG or biotinylated goat anti-mouse IgG. Tissue sections were then washed three times with PBS and incubated with streptavidin–peroxidase conjugate, followed by the addition of H2O2–DAB substrate–chromogen solution (Zymed Laboratories; South San Francisco, CA). Tissues were then counterstained with hematoxylin, dehydrated, mounted with Leica CV 5000 (Bartels and Stout Inc.; Issaquah, WA), and photographed with a Nikon Microphot-FXA light microscope (Tokyo, Japan). Immunostaining specificity was checked by treating control slides as described above except that the primary antibody was omitted.

Apoptosis Determination
Five-µm-thick tissue sections were deparaffinized with xylene, rehydrated in a graded series of ethanol, and washed with PBS solution. Tissue sections were incubated with proteinase K (20 µg/ml) at 37C for 15 min to expose the DNA for end labeling. For a positive control, tissue sections were exposed to 5 µg/ml DNase I in PBS at 37C for 60 min. After incubation, cell death was detected in tissue sections by a terminal deoxynucleotidyl transferase-mediated dUTP nick-end labeling (TUNEL) assay kit (Roche Diagnostics; Meylan, France) according to the manufacturer's instructions. After washing with PBS followed by double staining with 1 µg/ml DAPI at room temperature for 20 min in the dark for nucleus identification, tissue sections were examined under a Nikon Eclipse E400 fluorescence microscope.

Protein Extractions
Thoracic aorta were washed with PBS and homogenized in lysis buffer (10 mM Tris–HCl, pH 7.4, 1 mM benzamidine, 150 mM NaCl, 0.5 mM EDTA, 10 mg/ml phenyl methane sulfonyl fluoride) at 4C overnight. Cells were resuspended in lysis buffer and sonicated by Sonicator 3000 (Misonix Inc.; Farmingdale, NY) on ice. Supernatant was harvested by centrifugation at 900 x g at 4C for 10 min. Protein concentrations were measured by a BCA protein assay kit (Pierce; Rockford, IL), and the samples were stored at –20C until needed.

Western Blot Analysis
Proteins (5 µg) were separated by 12% SDS-PAGE and electrotransfered to a polyvinylidene fluoride membrane. Blots were probed with rabbit anti-human caveolin-1 antibody [1:10,000 (v/v); Santa Cruz Biotechnology] followed by horseradish peroxidase (HRP)-conjugated goat anti-rabbit IgG [1:15,000 (v/v); Zymed Laboratories]. SMC proliferation was detected with mouse anti-rat proliferating cellular nuclear antigen (PCNA) antibody [1:10,000 (v/v); Upstate, Charlottesville, VA] followed by HRP-conjugated goat anti-mouse IgG [1:15,000 (v/v)]. After washing with PBS containing 0.5% Tween-20, peroxidase activity was visualized using enhanced chemiluminescence (PerkinElmer Life Science; Boston, MA). The same membrane was re-probed with a monoclonal antibody directed against ß-actin [1:10,000 (v/v); Sigma, St Louis, MO] and goat anti-mouse immunoglobulin [1:10,000 (v/v); Zymed Laboratories) for an internal control. Intensity of reaction bands was analyzed by the Image Gauge System (Fuji; Tokyo, Japan).

Nitrite Production
Nitrite (NO2–) production was measured by the Griess reaction in 5 x 10-mm specimens from the thoracic aorta (Uemura et al. 2000). Specimens were incubated in 1 ml Hanks' buffered saline solution (HBSS; Hyclone, Logan, UT) at 37C for 2 hr. Samples of the medium (80 µl) were collected, and nitrite was measured by the Griess reaction and a commercial colorimetric assay system (Promega; Madison, WI).


   Results
Top
 Summary
 Introduction
 Materials and Methods
 Results
Discussion
 Literature Cited
 
Plasma Cholesterol Level
Total plasma cholesterol level in the controls remained in the normal range of 20–50 mg/dl. This level increased significantly from 1 to 12 weeks at all ages in high-cholesterol-fed rabbits (Figure 1 ).


Figure 1
View larger version (22K):
[in this window]
[in a new window]
  		Figure 1

Changes in mean total plasma cholesterol levels in New Zealand rabbits fed a high-cholesterol diet and a normal diet. All values are mean ± SE, n=20–40.

 
Distribution of Caveolin-1 in the Arterial Wall
Morphological observations indicated that the small lesions appeared in the thoracic aorta of rabbits fed a high-cholesterol diet until 5 weeks into the experiments. In rabbits fed cholesterol for 7–8 weeks, atherosclerotic streaks were observed in the coronary arteries, aortic arch, thoracic aorta, and carotid arteries. Large, raised plaques consisting of foam cells, mononuclear cells, and SMCs had formed in some areas within 8–12 weeks of the high-cholesterol diet. Progression of the atherogenic lesions was consistent with the results of other studies (Ross 1986Go,1997Go,1999Go; Lupu et al. 1987Go). Endothelial denudation was not observed in the tissue sections. Immunohistochemistry detected caveolin-1 predominantly in the intima of arterial vessels in rabbits fed normal and high-cholesterol diets for 5 weeks (Figures 2A –2C). Only a small amount of caveolin-1 was observed in some SMCs after high-cholesterol-diet treatment (Figure 2B). Staining intensity was higher in the high-cholesterol diet animals than in the control animals. No reaction products were found in sections in which the primary antibody had been omitted (Figure 2D). As the plaques started to form, staining intensity of caveolin-1 in the non-lesion areas is more intense than in the lesion areas (Figures 3A –3D). More advanced plaque contains foam cells as well as large quantities of extracellular matrix in rabbits fed a high-cholesterol diet for 12 weeks (Figures 4A and 4B). Many {alpha}-actin-positive cells indicated that the SMCs appeared in the plaques (Figure 4C). No reaction products were found in the sections with the primary antibody omitted (Figure 4D). Few to no TUNEL-positive cells were detected in the intima of atherogenic plaques in rabbits fed the high-cholesterol diet for 8 weeks (Figure 5A ). A significant number of TUNEL-positive cells was observed in the DNAase-treated tissue section (Figure 5B). These results demonstrated that most cells in the atherogenic plaques had not undergone apoptosis. DAPI staining shows the appearance of nucleus (Figures 5C and 5D).


Figure 2
View larger version (96K):
[in this window]
[in a new window]
  		Figure 2

Caveolin-1 distribution in aortic arch after 5 weeks on the normal diet (A) and high-cholesterol diet (B,C). Aortic arch (A,B). Coronary artery (C). Note that caveolin-1 is expressed mainly in the endothelial cells (arrows). A few reaction products appeared in smooth muscle cells (SMCs) (arrowhead in B). No reaction products were found in sections with the primary antibody omitted (D). L, lumen. Bar = 10 µm.

 

Figure 3
View larger version (51K):
[in this window]
[in a new window]
  		Figure 3

Staining intensity of caveolin-1 decreased in the plaque areas (arrows) of coronary artery (A) and aortic arch (B) in rabbits fed a high-cholesterol diet for 12 weeks. Staining intensity in a non-lesion area (arrow) is more intense than in the lesion area (arrowhead in C). Negative control (D). L, lumen. Bar = 5 µm.

 

Figure 4
View larger version (103K):
[in this window]
[in a new window]
  		Figure 4

Thoracic aorta of a rabbit after 12 weeks on the high-cholesterol diet (A). A plaque in the aortic intima containing foam cells and elastic fibers. At higher magnification, a mass of foam cells (arrowhead) as well as large quantities of extracellular matrix proteins (arrow) in the intima (B). {alpha}-Actin-positive cells (arrows) indicating SMCs in the plaque (C). No reaction products were found in the sections with the primary antibody omitted (D). (A,B) Hematoxylin and eosin. L, lumen. Bar = 10 µm.

 

Figure 5
View larger version (72K):
[in this window]
[in a new window]
  		Figure 5

Terminal deoxynucleotidyl transferase-mediated dUTP nick-end labeling (TUNEL) assay and DAPI staining were performed. Few to no TUNEL-positive cells were detected in the lesion area of aortic intima (A). A tissue section treated with DNase as the positive control (B). DAPI staining shows the appearance of nucleus (C,D). Bar = 5 µm.

 
Expression of Caveolin-1 and PCNA in the Arterial Wall
Western blot analysis showed that the level of caveolin-1 increased gradually in the vessel walls of control rabbits and reached its highest concentration at 12 weeks into the experiment (Figure 6A ). It also showed that the expression of caveolin-1 reached its highest level at 5 weeks and then decreased from 8 to 12 weeks in the rabbits fed a high-cholesterol diet (Figures 6B and 6C). PCNA levels decreased in the animals fed a high-cholesterol diet at 5 weeks and then increased at 8 and 12 weeks (Figures 6B and 6D).


Figure 6
View larger version (14K):
[in this window]
[in a new window]
  		Figure 6

Abundance of caveolin-1 in thoracic aorta of rabbits after 2–12 weeks on the normal diet and high-cholesterol diet. Caveolin-1 level increased gradually and reached its highest level at 12 weeks in the rabbits on the normal diet (A). Expression of caveolin-1 reached its highest level at 5 weeks and then decreased gradually after 8–12 weeks on the high-cholesterol diet (B,C). Proliferating cell nuclear antigen (PCNA) decreased to the lowest level at 5 weeks and then increased at 8 and 12 weeks (B,D).

 
Nitrite Production in the Arterial Wall
Nitrite production in the arterial walls gradually decreased in cholesterol-diet groups throughout the experiment. Nitrite level was significantly lower in animals fed the high-cholesterol diet after 5 and 8 weeks than the normal controls (Figure 7 ).


Figure 7
View larger version (14K):
[in this window]
[in a new window]
  		Figure 7

Nitrite production in the segments of thoracic aorta from rabbits fed normal and high-cholesterol diets for 8 weeks. Nitrite production gradually decreased in tissues from animals fed a high-cholesterol diet. Lower production of nitrite was observed in tissues from animals fed a high-cholesterol diet than in tissues from the control animals at 5 and 8 weeks. n=4–6 animals. All values are mean ± SE. *p<0.1.

 

   Discussion
Top
 Summary
 Introduction
 Materials and Methods
 Results
 Discussion
Literature Cited
 
To the best of our knowledge, this is the first in vivo study on the distribution and expression of caveolin-1 in the arterial walls of diet-induced hypercholesterolemic rabbits. The present study demonstrated that caveolin-1 increased and PCNA decreased in the early stages (5 weeks) of ingesting a high-cholesterol diet. At 8 and 12 weeks, the level of caveolin-1 decreased while the PCNA increased. Meantime, appearance of atherogenic plaques became more severe at 8 and 12 weeks. Nitrite production gradually decreased in the cholesterol feeding groups.

Hypercholesterolemia is a crucial factor of atherosclerosis, a process histologically characterized by lesions progressing from fatty streaks to fibrous plaques, ultimately occluding the lumen of the affected artery (Ross 1993Go). Several studies have suggested that caveolin-1 and caveolae may play a proatherogenic role by promoting the transcytosis of LDL particles from the blood to the subendothelial space (Palade 1953Go; Fielding and Fielding 1996Go). It has been demonstrated that diet-induced hypercholesterolemia may increase the permeability of endothelium, allowing LDLs to infiltrate and accumulate in the intima (Lee et al. 2001Go). Furthermore, one study reported that the plasmalemmal caveolae and the open junctions increased significantly in the branched regions of arteries in hypercholesterolemic rats (Kao et al. 1995Go). In this study, the concentration of plasma LDL cholesterol increased from 140 mg/dl to 1250 mg/dl between 2 and 5 weeks after high-cholesterol-diet treatment. The fatty streak did not start to appear in the intima until week 5. Concomitantly, the level of caveolin-1 increased and reached its highest level at about 5–6 weeks; at that time, the level of caveolin-1 began to decrease. It has been reported that caveolin-1 is more abundant in endothelial cells than in SMCs (Frank and Lisanti 2004Go). Our immunohistochemical results also showed that caveolin-1 is expressed predominantly in the endothelial cells. We felt that the increased caveolin-1 shown in the result of Western blotting was mainly due to the endothelium.

Several in vitro studies have shown that overexpression of caveolin-1 enhanced the cholesterol efflux in the culture system. Free cholesterol and oxysterols could modify free cholesterol efflux by means of opposite effects on the expression of caveolin (Lisanti et al. 1994Go; Fielding et al. 2002Go). In confluent fibroblast monolayers, caveolin mRNA levels are upregulated when increased levels of cholesterol enter the cell from LDL. The upregulation of caveolin-1 expression may represent a protective mechanism against cellular cholesterol accumulation in these cells. On the contrary, oxysterols reduced caveolin mRNA levels, as well as transport of cholesterol to the cell surface and cholesterol efflux (Fielding et al. 1997Go). Oxysterols are formed from free cholesterol when it combines with oxygen. 7-Ketocholesterol and 7-{alpha}-hydroxy cholesterol are major components of human atherosclerotic lesions (Fielding et al. 1997Go). Accumulation of oxidized (ox) LDL in the intima after long periods of feeding is thought to be involved in the development of atherosclerosis. Among the multiple cell types in the vascular system, the accumulation of oxLDL was chemotactic to monocytes and SMCs. We assume from our results that, in the early stage of hypercholesterolemia, caveolin-1 synthesis increased to remove the excess cholesterol from the cells. However, after long periods of feeding, caveolin-1 synthesis was repressed. It has been reported that reactive oxygen species (ROS) are profound activators of signal transduction events that may alter eNOS phosphorylation, resulting in the dysfunction of endothelial function. Additional work will be needed to clarify the role of long-term hypercholesterolemia in the regulation of caveolin-1 expression.

A recent study by Zulli et al. (2006)Go indicated that the expression of caveolin-1 in the endothelium-overlying plaques is increased. They used a combination diet (0.5% high-cholesterol diet plus 1% methionine) to induce hyperhomocysteinemia and hypercholesterolemia in the rabbit for 12 weeks. On the contrary, we used 2% high-cholesterol diet to induce hypercholesterolemia. The morphology of plaques in Zulli's paper was different from what we observed in our experiment. For example, we found foam cells and extracellular matrix in the plaques. Results similar to ours have been reported in previous studies (Ross 1986Go,1993Go, 1997Go,1999Go). We assume that the different experimental design may have caused the different results.

Endothelium-derived NO modulates vasodilation and prevents platelet adhesion and SMC proliferation. NO has also been shown to have antioxidant effects by enhancing the expression of superoxide dismutase, preventing lipid-chain reactions, and reacting with the superoxide anion. Thus, NO seems to play a major role as an endogenous protective factor against atherosclerosis. Caveolin-1 in endothelial cells has been reported to negatively regulate eNOS activity (Razani et al. 2001Go). For example, NOS became hyperactivated in the absence of caveolin-1 (Shaul et al. 1996Go). The ability of caveolin-1 to inhibit eNOS might also contribute to the regulation of vascular permeability (Fukumura et al. 2001Go). In this study, NOS activity decreased gradually in high-cholesterol diet groups. In other words, after a long period of ingesting a high-cholesterol diet, both the level of caveolin-1 and the activity of NOS decreased. It has been reported that dietary cholesterol reduced endothelium-dependent relaxations and decreased NO production (Boger et al. 1995Go). Enhanced superoxide anion (O2–) production may further contribute to the decreased biological activity of NO in hypercholesterolemia. For example, ROS were shown to inhibit cholesterol-mediated increases in caveolae number in bovine aortic endothelial cells (Peterson et al. 2003Go).

SMC proliferation is one of the important events in the development of atherosclerosis. The regulation of eNOS by caveolin-1 in endothelial cells may indirectly affect neighboring SMCs in the arterial walls that are prone to the development of atherosclerosis. One study has reported that genetic ablation of caveolin-1 in mice stimulates the proliferation of SMCs (Hassan et al. 2004Go). It has also been shown that the transition of SMCs from a contractile to a synthetic phenotype is associated with a loss of plasma membrane caveolae. Several reports have proposed an antiproliferative and possibly antimigratory role for caveolin-1 (Peterson et al. 2003Go). In this study, we demonstrated that the decreasing level of caveolin-1 was associated with increasing SMC proliferation in the arterial walls of hypercholesterolemic rabbits. This finding provides new information about the role caveolin-1 plays in atherosclerotic formation in vivo. Regulation of caveolin-1 expression may be important in the prevention and treatment of atherosclerosis.


   Acknowledgments
 
This work was supported by research grant TCVGHT-T-927802 from the Taichung Veterans General Hospital and research grant THU 2208-74-62 from the Tunghai University, Taiwan, Republic of China.

The technical assistance of S.H. Tsai is gratefully acknowledged.


   Footnotes
 
Received for publication November 11, 2005; accepted March 11, 2006


   Literature Cited
Top
 Summary
 Introduction
 Materials and Methods
 Results
 Discussion
 Literature Cited
 

Boger RH, Bode-Boger SM, Mugge A, Kienke S, Brandes R, Dwenger A, Frolich JC (1995) Supplementation of hypercholesterolemic rabbits with L-arginine reduces the vascular release of superoxide anions and restores NO production. Atherosclerosis 117:273–284[CrossRef][Medline]

Bucci M, Gratton JP, Rudic RD, Acevedo L, Roviezzo F, Cirino G, Sessa WC (2000) In vivo delivery of the caveolin-1 scaffolding domain inhibits nitric oxide synthesis and reduces inflammation. Nat Med 6:1362–1367[CrossRef][Medline]

Chang WJ, Ying YS, Rothberg KG, Hooper NM, Turner AJ, Gambliel HA, De Gunzburg J, et al. (1994) Purification and characterization of smooth muscle cell caveolae. J Cell Biol 126:127–138[Abstract/Free Full Text]

Drab M, Verkade P, Elger M, Kasper M, Lohn M, Lauterbach B, Menne J, et al. (2001) Loss of caveolae, vascular dysfunction, and pulmonary defects in caveolin-1 gene-disrupted mice. Science 293:2449–2452[Abstract/Free Full Text]

Drexler H (1999) Nitric oxide and coronary endothelial dysfunction in humans. Cardiovasc Res 43:572–579[Free Full Text]

Elias JM, Margiotta M, Gaborc D (1989) Sensitivity and detection efficiency of the peroxidase antiperoxidase (PAP), avidin-biotin peroxidase complex (ABC), and peroxidase-labeled avidin-biotin (LAB) methods. Am J Clin Pathol 92:62–67[Medline]

Feron O, Dessy C, Desager JP, Balligand JL (2001) Hydroxy-methylglutaryl-coenzyme A reductase inhibition promotes endothelial nitric oxide synthase activation through a decrease in caveolin abundance. Circulation 103:113–118[Abstract/Free Full Text]

Feron O, Dessy C, Moniotte S, Desager JP, Balligand JL (1999) Hypercholesterolemia decreases nitric oxide production by promoting the interaction of caveolin and endothelial nitric oxide synthase. J Clin Invest 103:897–905[Medline]

Feron O, Kelly RA (2001) The caveolar paradox: suppressing, inducing, and terminating eNOS signaling. Circ Res 88:129–131[Free Full Text]

Fielding CJ, Bist A, Fielding PE (1997) Caveolin mRNA levels are up-regulated by free cholesterol and down-regulated by oxysterols in fibroblast monolayers. Proc Natl Acad Sci USA 94:3753–3758[Abstract/Free Full Text]

Fielding CJ, Fielding PE (1997) Intracellular cholesterol transport. J Lipid Res 38:1503–1521[Abstract]

Fielding PE, Fielding CJ (1996) Intracellular transport of low density lipoprotein derived free cholesterol begins at clathrin-coated pits and terminates at cell surface caveolae. Biochemistry 35:14932–14938[CrossRef][Medline]

Fielding PE, Russel JS, Spencer TA, Hakamata H, Nagao K, Fielding CJ (2002) Sterol efflux to apolipoprotein A-I originates from caveolin-rich microdomains and potentiates PDGF-dependent protein kinase activity. Biochemistry 41:4929–4937[CrossRef][Medline]

Frank PG, Galbiati F, Volonte D, Razani B, Cohen DE, Marcel YL, Lisanti MP (2001) Influence of caveolin-1 on cellular cholesterol efflux mediated by high-density lipoproteins. Am J Physiol Cell Physiol 280:C1204–1214[Abstract/Free Full Text]

Frank PG, Lisanti MP (2004) Caveolin-1 and caveolae in atherosclerosis: differential roles in fatty streak formation and neointimal hyperplasia. Curr Opin Lipidol 15:523–529[CrossRef][Medline]

Fu Y, Hoang A, Escher G, Parton RG, Krozowski Z, Sviridov D (2004) Expression of caveolin-1 enhances cholesterol efflux in hepatic cells. J Biol Chem 279:14140–14146[Abstract/Free Full Text]

Fukumura D, Gohongi T, Kadambi A, Izumi Y, Ang J, Yun CO, Buerk DG, et al. (2001) Predominant role of endothelial nitric oxide synthase in vascular endothelial growth factor-induced angiogenesis and vascular permeability. Proc Natl Acad Sci USA 98:2604–2609[Abstract/Free Full Text]

Garg UC, Hassid A (1989) Nitric oxide-generating vasodilators and 8-bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells. J Clin Invest 83:1774–1777[Medline]

Hassan GS, Jasmin J-F, Schubert W, Frank PG, Lisanti MP (2004) Caveolin-1 deficiency stimulates neointima formation during vascular injury. Biochemistry 43:8312–8321[CrossRef][Medline]

Huo Y, Ley K (2001) Adhesion molecules and atherogenesis. Acta Physiol Scand 173:35–43[CrossRef][Medline]

Kao CH, Chen JK, Kuo JS, Yang VC (1995) Visualization of the transport pathways of low density lipoproteins across the endothelial cells in the branched regions of rat arteries. Atherosclerosis 116:27–41[CrossRef][Medline]

Kawashima S, Yamashita T, Ozaki M, Ohashi Y, Azumi H, Inoue N, Hirata K, et al. (2001) Endothelial NO synthase overexpression inhibits lesion formation in mouse model of vascular remodeling. Arterioscler Thromb Vasc Biol 21:201–207[Abstract/Free Full Text]

Lee WC, Chao WT, Yang VC (2001) Effects of high-cholesterol diet on the interendothelial clefts and the associated junctional complexes in rat aorta. Atherosclerosis 155:307–312[CrossRef][Medline]

Lisanti MP, Scherer PE, Vidugiriene J, Tang Z, Hermanowski-Vosatka A, Tu YH, Cook RF, et al. (1994) Characterization of caveolin-rich membrane domains isolated from an endothelial-rich source: implications for human disease. J Cell Biol 126:111–126[Abstract/Free Full Text]

Lupu F, Danaricu I, Simionescu N (1987) Development of intracellular lipid deposits in the lipid-laden cells of atherosclerotic lesions. Atherosclerosis 67:127–142[CrossRef][Medline]

Matveev S, van der Westhuyzen DR, Smart EJ (1999) Co-expression of scavenger receptor-BI and caveolin-1 is associated with enhanced selective cholesteryl ester uptake in THP-1 macrophages. J Lipid Res 40:1647–1654[Abstract/Free Full Text]

Palade GE (1953) Fine structure of blood capillaries. J Appl Phys 24:1424

Peterson TE, Guicciardi ME, Gulati R, Kleppe LS, Mueske CS, Mookadam M, Sowa G, et al. (2003) Caveolin-1 can regulate vascular smooth muscle cell fate by switching platelet-derived growth factor signaling from a proliferative to an apoptotic pathway. Arterioscler Thromb Vasc Biol 23:1521–1527[Abstract/Free Full Text]

Piech A, Massart PE, Dessy C, Feron O, Havaux X, Morel N, Vanoverschelde JL, et al. (2002) Decreased expression of myocardial eNOS and caveolin in dogs with hypertrophic cardiomyopathy. Am J Physiol Heart Circ Physiol 282:H219–231[Abstract/Free Full Text]

Ratajczak P, Damy T, Heymes C, Oliviero P, Marotte F, Robidel E, Sercombe R, et al. (2003) Caveolin-1 and -3 dissociations from caveolae to cytosol in the heart during aging and after myocardial infarction in rat. Cardiovasc Res 57:358–369[Abstract/Free Full Text]

Razani B, Engelman JA, Wang XB, Schubert W, Zhang XL, Marks CB, Macaiuso F, et al. (2001) Caveolin-1 null mice are viable but show evidence of hyperproliferative and vascular abnormalities. J Biol Chem 276:38121–38138[Abstract/Free Full Text]

Ross R (1986) The pathogenesis of atherosclerosis—an update. N Engl J Med 314:488–500[Medline]

Ross R (1993) The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 362:801–809[CrossRef][Medline]

Ross R (1997) Cellular and molecular studies of atherosclerosis. Atherosclerosis 131(suppl):S3–4

Ross R (1999) Atherosclerosis—an inflammatory disease. N Engl J Med 340:115–126[Free Full Text]

Scherer PE, Lewis RY, Volonte D, Engelman JA, Galbiati F, Couet J, Kohtz DS, et al. (1997) Cell-type and tissue-specific expression of caveolin-2. Caveolins 1 and 2 co-localize and form a stable hetero-oligomeric complex in vivo. J Biol Chem 272:29337–29346[Abstract/Free Full Text]

Shaul PW, Smart EJ, Robinson LJ, German Z, Yuhanna IS, Ying Y, Anderson RGW, et al. (1996) Acylation targets endothelial nitric-oxide synthase to plasmalemmal caveolae. J Biol Chem 271:6518–6522[Abstract/Free Full Text]

Smart EJ, Graf GA, McNiven MA, Sessa WC, Engelman JA, Scherer PE, Okamoto T, et al. (1999) Caveolins, liquid-ordered domains, and signal transduction. Mol Cell Biol 19:7289–7304[Free Full Text]

Takahashi M, Ikeda U, Masuyama J, Funayama H, Kano S, Shimada K (1996) Nitric oxide attenuates adhesion molecule expression in human endothelial cells. Cytokine 8:817–821[CrossRef][Medline]

Uemura S, Fathman CG, Rothbard JB, Cooke JP (2000) Rapid and efficient vascular transport of arginine polymer inhibits myointimal hyperplasia. Circulation 102:2629–2635[Abstract/Free Full Text]

Zulli A, Buxton BF, Black MJ, Ming Z, Cameron A, Hare DL (2006) The immunoquantification of caveolin-1 and eNOS in human and rabbit diseased blood vessels. J Histochem Cytochem 54:151–159[Abstract/Free Full Text]


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?



This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jhc.5A6869.2006v1
54/8/897    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lin, W.-W.
Right arrow Articles by Yang, V. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lin, W.-W.
Right arrow Articles by Yang, V. C.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?


Guidelines | Subscriptions | About | exPRESS - Current - Archive | Business Information | Contact